10.1002/chem.201704554
Chemistry - A European Journal
FULL PAPER
(0.16 mL, 1.7 mmol) and catalytic amounts of DMAP were added
sequentially to a solution of 8,8″-biskoenigine (9) (343 mg, 0.556 mmol)
in THF (38 mL) and the mixture was stirred at room temperature for 2 h.
The mixture was diluted with diethyl ether and extracted with a saturated
aqueous solution of ammonium chloride. The aqueous layer was
extracted with diethyl ether, the combined organic layers were dried
(magnesium sulfate) and the solvent was evaporated. Purification of the
residue by column chromatography (silica gel; isohexane/ethyl acetate,
3:1) provided the diacetate 27 (363 mg, 0.518 mmol, 93%) as light brown
solid. M.p. 173–174 °C; UV (MeOH): λ = 234, 287 (sh), 298, 338, 355
(sh) nm; fluorescence (MeOH): λex = 298 nm, λem = 392 nm; IR (ATR): ν
= 3409, 2971, 1754, 1642, 1475, 1418, 1366, 1289, 1216, 1165, 1129,
1028, 981, 894, 776, 728 cm−1; 1H NMR (500 MHz, CDCl3): δ = 1.38 (s, 6
H), 1.47 (s, 6 H), 1.97 (s, 6 H), 2.33 (s, 6 H), 4.01 (s, 6 H), 5.57 (d, J =
9.8 Hz, 2 H), 6.51 (d, J = 9.8 Hz, 2 H), 7.60 (s, 2 H), 7.64 (s, 2 H), 7.99
(br s, 2 H); 13C NMR (125 MHz, CDCl3): δ = 16.12 (2 CH3), 20.55 (2 CH3),
27.25 (2 CH3), 27.90 (2 CH3), 56.73 (2 CH3), 75.93 (2 C), 102.80 (2 CH),
104.89 (2 C), 109.93 (2 C), 116.42 (2 C), 117.37 (2 CH), 118.66 (2 C),
120.54 (2 CH), 121.02 (2 C), 129.09 (2 CH), 132.96 (2 C), 135.42 (2 C),
sodium thiosulfate was added and the mixture was extracted twice with
ethyl acetate. The combined organic layers were dried (magnesium
sulfate) and the solvent was evaporated. Purification of the residue by
column chromatography (silica gel; isohexane/ethyl acetate, gradient
15:1 to 10:1) provided bismurrayafoline B (11) (37.6 mg, 63.9 µmol, 76%)
as as brown solid. M.p. 123 °C; UV (MeOH): λ = 233, 251 (sh), 259, 303,
322 (sh), 335 (sh) nm; fluorescence (MeOH): λex = 303 nm, λem = 369
nm; IR (ATR): ν = 3511, 3448, 3408, 2952, 2914, 2853, 2826, 1725,
1696, 1619, 1565, 1474, 1444, 1372, 1326, 1219, 1171, 1081, 1041, 968,
1
847, 792 cm−1; H NMR (500 MHz, CDCl3): δ = 1.74 (s, 6 H), 1.90 (s, 6
H), 2.16 (s, 6 H), 3.66 (d, J = 6.7 Hz, 4 H), 3.95 (s, 6 H), 4.97 (br s, 2 H),
5.34 (m, 2 H), 6.91 (d, J = 8.6 Hz, 2 H), 7.59 (s, 2 H), 7.85 (d, J = 8.5 Hz,
2 H), 8.06 (br s, 2 H); 13C NMR and DEPT (125 MHz, CDCl3): δ = 18.14
(2 CH3), 20.12 (2 CH3), 24.09 (2 CH2), 25.87 (2 CH3), 56.79 (2 CH3),
105.12 (2 CH), 111.64 (2 C), 113.33 (2 CH), 114.74 (2 C), 117.92 (2 C),
118.55 (2 CH), 122.39 (2 CH), 126.00 (2 C), 127.14 (2 C), 129.34 (2 C),
133.12 (2 C), 139.52 (2 C), 140.75 (2 C), 155.94 (2 C); MS (ESI, +25 V):
m/z = 589.9 [M+H]+; MS (ESI, −75 V): 587.5 [M−H]−; HRMS (ESI): m/z
calcd for C38H40N2O4: 588.2988; found: 588.2977.
1
136.33 (2 C), 145.77 (2 C), 149.77 (2 C) 171.16 (2 C=O); H NMR (500
MHz, DMSO-d6): δ = 1.36 (s, 6 H), 1.37 (s, 6 H), 1.85 (s, 6 H), 2.26 (s, 6
H), 3.89 (s, 6 H), 5.58 (d, J = 9.9 Hz, 2 H), 6.95 (d, J = 10.0 Hz, 2 H),
7.78 (s, 2 H), 7.80 (s, 2 H), 10.10 (s, 2 H); 13C NMR (125 MHz, DMSO-
d6): δ = 16.00 (2 CH3), 20.22 (2 CH3), 27.34 (4 CH3), 56.25 (2 CH3),
75.30 (2 C), 102.61 (2 CH), 104.63 (2 C), 110.25 (2 C), 116.56 (2 C),
116.63 (2 C), 118.78 (2 CH), 119.99 (2 C), 120.56 (2 CH), 127.95 (2 CH),
133.54 (2 C), 135.70 (2 C), 136.29 (2 C), 145.24 (2 C), 148.62 (2 C),
167.97 (2 C=O); MS (ESI, +25 V): m/z = 701.6 [M+H]+; MS (ESI, −25 V):
m/z = 699.3 [M−H]−; MS (EI): m/z = 700 (77) [M]+, 658 (100), 643 (24),
616 (62), 601 (55), 293 (40); HRMS (EI): m/z calcd for C42H40N2O8:
700.2785; found: 700.2771.
1-Hydroxy-7-methoxy-3-methyl-8-(3,7-dimethylocta-2,6-dien-1-yl)-
carbazole (murrayafoline D) (31): Lithium aluminum hydride (138.2 mg,
3.64 mmol) was added at room temperature to a solution of carbazolyl
tosylate 30 (ratio of E/Z = 1.4:1; 268.8 mg, 519 µmol)85 in THF (30 mL)
and the mixture was heated at reflux for 23 h. After cooling to 0 °C, a
saturated aqueous solution of potassium sodium tartrate was added and
the mixture was extracted twice with ethyl acetate. The combined organic
layers were dried (MgSO4) and the solvent was evaporated. Purification
of the residue by column chromatography (silica gel, isohexane/ethyl
acetate, 10:1) provided the 1-hydroxycarbazole 31 (84.4 mg, 232 µmol,
45%; light brown, highly viscous oil) as a mixture of diastereoisomers
(ratio of E/Z = 1.4:1). UV (MeOH): λ = 231, 246, 256, 301 nm;
fluorescence (MeOH): λex = 231 nm, λem = 368 nm; IR (ATR): ν = 3366,
2959, 2915, 2853, 1620, 1590, 1512, 1491, 1448, 1417, 1374, 1350,
The atropisomers of compound 27 were separated by chiral HPLC (72%
20
eluent B, isocratic). Isomer 1: [α]D −301 (c = 0.073, CHCl3); m.p. 170–
171 °C. Isomer 2: [α]D20 +304 (c = 0.070, CHCl3); m.p. 174–175 °C.
1325, 1253, 1220, 1173, 1083, 975, 874, 830, 791 cm−1 1H NMR (600
;
MHz, CDCl3): 1.55 (E, s) and 1.65 (Z, s, 3 H), 1.60 (E, d, J = 0.9 Hz) and
1.70 (Z, d, J = 0.8 Hz, 3 H), 1.74 (Z, d, J = 1.2 Hz) and 1.89 (E, d, J = 0.5
Hz, 3 H), 2.01–2.07 (E, m) and 2.31–2.36 (Z, m, 2 H), 2.07–2.13 (E, m)
and 2.17–2.24 (Z, m, 2 H), 2.44 (s, 3 H), 3.64 (d, J = 6.8 Hz, 2 H), 3.906
(Z, s) and 3.912 (E, s, 3 H), 4.86 (br. s, 1 H), 5.04–5.09 (E, m) and 5.21–
5.25 (Z, m, 1 H), 5.30–5.36 (m, 1 H), 6.57 (s, 1 H), 6.84 (Z, d, J = 8.5 Hz)
and 6.85 (E, d, J = 8.5 Hz, 1 H), 7.36 (s, 1 H), 7.768 (Z, d, J = 8.5 Hz)
and 7.771 (E, d, J = 8.5 Hz, 1 H), 7.96 (Z, s) and 7.97 (E, s, 1 H); 13C
NMR (150 MHz, CDCl3): 16.34 (E) and 23.34 (Z, CH3), 17.65 (E) and
17.71 (Z, CH3), 21.45 (CH3), 23.62 and 23.86 (CH2), 25.60 (E) and 25.72
(Z, CH3), 26.49 (E) and 26.68 (Z, CH2), 32.18 (Z) and 39.71 (E, CH2),
56.61 (Z) and 56.70 (E, CH3), 104.69 (Z) and 104.78 (E, CH), 111.32 and
111.35 (CH), 111.40 and 111.43 (C), 112.49 (CH), 118.03 (C), 118.33
(E) and 118.35 (Z, CH), 122.22 (E) and 122.91 (Z, CH), 124.12 (E) and
124.17 (Z, CH), 125.87 and 125.90 (C), 127.25 (C), 129.42 and 129.43
(C), 131.58 and 132.0 (C), 136.56 and 136.77 (C), 140.40 and 140.41
(C), 140.52 and 140.60 (C), 155.51 and 155.56 (C); MS (ESI, +10 V): m/z
= 364.2 [M+H]+, 727.5 [2M+H]+; MS (ESI, −50 V): m/z = 361.9 [M−H]-,
725.1 [2M−H]−; HRMS (ESI): m/z calcd for C24H29NO2: 363.2198; found:
363.2192.
1,1′-Dihydroxy-6,6′-dimethoxy-3,3′-dimethyl-2,2′-bicarbazole
(bisclausenol) (10): Di-tert-butyl peroxide (0.06 mL, 0.05 g, 0.3 mmol)
was added to
a solution of clausenol (1-hydroxy-6-methoxy-3-
methylcarbazole) (28) (51.6 mg, 0.227 mmol) in chlorobenzene (5 mL)
and the mixture was heated at reflux for 2 h. After cooling to room
temperature, the solvent was evaporated and the residue was purified by
column chromatography (silica gel; hexane/ethyl acetate, 2:1) to provide
bisclausenol (10) (47.9 mg, 0.106 mmol, 93%) as light yellow crystals.
M.p. >250 °C (dec.); UV (EtOH): λ = 228, 254, 293 (sh), 303, 342, 357
nm; fluorescence (EtOH): λex = 303 nm; λem = 388 nm; IR (ATR): ν =
3403, 3349, 2920, 2830, 2508, 1686, 1621, 1562, 1542, 1522, 1492,
1474, 1459, 1436, 1384, 1338, 1297, 1260, 1206, 1150, 1089, 1057,
1014, 987, 953, 866, 835, 806, 778, 765 cm−1 1H NMR (500 MHz,
;
acetone-d6): δ = 2.09 (s, 6 H), 3.91 (s, 6 H), 7.04 (dd, J = 8.7, 2.5 Hz, 2
H), 7.45 (s, 2 H), 7.48 (d, J = 8.7 Hz, 2 H), 7.56 (s, 2 H), 7.63 (d, J = 2.4
Hz, 2 H), 9.94 (s, 2 H); 13C NMR and DEPT (125 MHz, acetone-d6): δ =
20.56 (2 CH3), 56.05 (2 CH3), 103.34 (2 CH), 112.72 (2 CH), 113.33 (2
CH), 115.50 (2 CH), 118.69 (2 C), 124.69 (2 C), 125.03 (2 C), 129.16 (2
C), 130.20 (2 C), 135.96 (2 C), 141.92 (2 C), 154.57 (2 C); MS (ESI, +25
V): m/z = 453.2 [M+H]+; 927.4 [2M+Na]+; MS (ESI, −50 V): m/z = 451.0
[M−H]−; 903.1 [2M−H]−; HRMS (ESI): m/z calcd for C28H24N2O4:
452.1736; found: 452.1732.
1,1′-Dihydroxy-7,7′-dimethoxy-3,3′-dimethyl-8,8′-bis(3,7-
dimethylocta-2,6-dien-1-yl)-2,2′-bicarbazole (bismurrayafoline D)
(12): Lithium aluminum hydride (2.4 M in THF, 0.6 mL, 1.4 mmol) was
added at room temperature to a solution of carbazolyl tosylate 30 (ratio of
E/Z = 1.3:1; 83.9 mg, 0.162 mmol)85 in THF (10 mL) and the mixture was
heated at reflux for 16 h. After cooling to 0 °C, a saturated aqueous
solution of potassium sodium tartrate was added and the mixture was
extracted with twice ethyl acetate. The combined organic layers were
Bismurrayafoline
8,8′-bis(3-methylbut-2-en-1-yl)-2,2′-bicarbazole) (11):
B
(1,1′-dihydroxy-7,7′-dimethoxy-3,3′-dimethyl-
mixture of
A
murrayafoline-B (29) (50.0 mg, 0.170 mmol), di-tert-butyl peroxide (37.0
mg, 0.253 mmol) and chlorobenzene (15 mL) was heated at reflux for 2 h.
After cooling to room temperature, a saturated aqueous solution of
This article is protected by copyright. All rights reserved.